Beyond sicca symptoms, Sjögren's disease can involve non-glandular manifestations such as dysautonomia and small fiber neuropathy that are often difficult to assess and manage. At this year's American ...

A new, inexpensive urine test that measures two sugar alcohols, sorbitol and xylitol, is making it easier, faster, and far less expensive to identify a common inherited nerve disorder called ...

As we get into another winter holiday season, COVID is still part of our lives. And although it's hard to predict exactly what this year's cold, flu and coronavirus season will look like, experts want ...

Decision follows China's expansion of nuclear stockpile Kremlin reacts cautiously to Trump's nuclear remarks Russia's recent nuclear tests include Poseidon super torpedo Pentagon expects Chinese ...

President Donald Trump on Thursday vowed to begin testing US nuclear weapons “on an equal basis” with Russia and China, heralding a potentially major shift in decades of US policy at a time of growing ...

Introduction: Cardiovascular autonomic neuropathy (CAN) is a severe complication of diabetes that impairs the regulation of the cardiovascular system. This can cause hemodynamic instability, ...

Jeff Smith was dumbfounded when he received a colon cancer screening kit in the mail. The 68-year-old Minnesota man hadn't asked for the Cologuard test, and his doctor hadn't mentioned anything about ...

"Our goal was that the NAFCS Score would not require specialized research assays or genetic testing, although it could be used to prompt or complement genetic testing…Our hope is that this tool will ...

The federal government program that mailed free at-home COVID-19 tests to households is no longer active. Some insurance providers may still cover the cost of at-home tests, and free tests may be ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

A Vertex Pharmaceuticals drug viewed as a successor to a non-opioid pill that won a landmark FDA approval earlier this year has failed a mid-stage clinical trial, dealing a setback to the company’s ...